BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36658130)

  • 21. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
    Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
    Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morin enhances auranofin anticancer activity by up-regulation of DR4 and DR5 and modulation of Bcl-2 through reactive oxygen species generation in Hep3B human hepatocellular carcinoma cells.
    Hwang-Bo H; Lee WS; Nagappan A; Kim HJ; Panchanathan R; Park C; Chang SH; Kim ND; Leem SH; Chang YC; Kwon TK; Cheong JH; Kim GS; Jung JM; Shin SC; Hong SC; Choi YH
    Phytother Res; 2019 May; 33(5):1384-1393. PubMed ID: 30887612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcumin.
    Yoon MJ; Kang YJ; Lee JA; Kim IY; Kim MA; Lee YS; Park JH; Lee BY; Kim IA; Kim HS; Kim SA; Yoon AR; Yun CO; Kim EY; Lee K; Choi KS
    Cell Death Dis; 2014 Mar; 5(3):e1112. PubMed ID: 24625971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma.
    Raninga PV; Di Trapani G; Vuckovic S; Bhatia M; Tonissen KF
    Oncotarget; 2015 Jun; 6(17):15410-24. PubMed ID: 25945832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
    Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
    Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells.
    Zheng P; Xia Y; Shen X; Lu H; Chen Y; Xu C; Qiu C; Zhang Y; Zou P; Cui R; Huang X
    Int J Biol Sci; 2024; 20(1):249-264. PubMed ID: 38164168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The thioredoxin system in breast cancer cell invasion and migration.
    Bhatia M; McGrath KL; Di Trapani G; Charoentong P; Shah F; King MM; Clarke FM; Tonissen KF
    Redox Biol; 2016 Aug; 8():68-78. PubMed ID: 26760912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis.
    Lee DM; Kim IY; Lee HJ; Seo MJ; Cho MY; Lee HI; Yoon G; Ji JH; Park SS; Jeong SY; Choi EK; Choi YH; Yun CO; Yeo M; Kim E; Choi KS
    Cell Death Dis; 2024 Jan; 15(1):48. PubMed ID: 38218922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indirubin-3'-monoxime induces paraptosis in MDA-MB-231 breast cancer cells by transmitting Ca
    Dilshara MG; Neelaka Molagoda IM; Prasad Tharanga Jayasooriya RG; Choi YH; Park C; Kim GY
    Arch Biochem Biophys; 2021 Feb; 698():108723. PubMed ID: 33321111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
    Du Y; Zhang H; Lu J; Holmgren A
    J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines.
    Miyahara K; Kazama H; Kokuba H; Komatsu S; Hirota A; Takemura J; Hirasawa K; Moriya S; Abe A; Hiramoto M; Ishikawa T; Miyazawa K
    Int J Oncol; 2016 Nov; 49(5):1848-1858. PubMed ID: 27601063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death.
    Kim IY; Shim MJ; Lee DM; Lee AR; Kim MA; Yoon MJ; Kwon MR; Lee HI; Seo MJ; Choi YW; Choi KS
    Biochem Pharmacol; 2019 Apr; 162():41-54. PubMed ID: 30529689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells.
    Yoon MJ; Kim EH; Lim JH; Kwon TK; Choi KS
    Free Radic Biol Med; 2010 Mar; 48(5):713-26. PubMed ID: 20036734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90.
    Wang WB; Feng LX; Yue QX; Wu WY; Guan SH; Jiang BH; Yang M; Liu X; Guo DA
    J Cell Physiol; 2012 May; 227(5):2196-206. PubMed ID: 21866552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase.
    Malin D; Lee Y; Chepikova O; Strekalova E; Carlson A; Cryns VL
    Breast Cancer Res Treat; 2021 Dec; 190(3):373-387. PubMed ID: 34553295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of thioredoxin and its reductase attenuates arsenic trioxide‑induced growth suppression in human pulmonary artery smooth muscle cells by reducing oxidative stress.
    Park WH
    Oncol Rep; 2020 Jan; 43(1):358-367. PubMed ID: 31789420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer.
    Freire Boullosa L; Van Loenhout J; Flieswasser T; De Waele J; Hermans C; Lambrechts H; Cuypers B; Laukens K; Bartholomeus E; Siozopoulou V; De Vos WH; Peeters M; Smits ELJ; Deben C
    Redox Biol; 2021 Jun; 42():101949. PubMed ID: 33812801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective inhibition of endogenous antioxidants with Auranofin causes mitochondrial oxidative stress which can be countered by selenium supplementation.
    Radenkovic F; Holland O; Vanderlelie JJ; Perkins AV
    Biochem Pharmacol; 2017 Dec; 146():42-52. PubMed ID: 28947276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
    Raninga PV; Lee AC; Sinha D; Shih YY; Mittal D; Makhale A; Bain AL; Nanayakarra D; Tonissen KF; Kalimutho M; Khanna KK
    Int J Cancer; 2020 Jan; 146(1):123-136. PubMed ID: 31090219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Honokiol induces paraptosis-like cell death of acute promyelocytic leukemia via mTOR & MAPK signaling pathways activation.
    Liu X; Gu Y; Bian Y; Cai D; Li Y; Zhao Y; Zhang Z; Xue M; Zhang L
    Apoptosis; 2021 Apr; 26(3-4):195-208. PubMed ID: 33550458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.